Lodo Therapeutics
Subodh Deshmukh has over 20 years of experience across all stages of product development, from research to engineering and launch management at global scale. He most recently served as Global Head of Product Development for Novartis/ Sandoz, and has through his career led the innovation and development of several blockbuster products including, life saving therapies that benefit millions of people.
Subodh holds a Ph.D. in Chemical Engineering from the University of Pittsburgh and an MBA from the Wharton School, University of Pennsylvania.
This person is not in any offices
Lodo Therapeutics
1 followers
Lodo Therapeutics discovers and develops novel therapeutics addressing "undruggable" targets with high unmet need by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA.